Structural characterization of BRCT-tetrapeptide binding interactions

Biochemical and Biophysical Research Communications

Volumn 393, Issue 2, 2010, Pages 207-210

  Joseph, Prem Raj B ^a   Yuan, Ziyan ^a,c   Kumar, Eric A ^a,c   Lokesh, G L ^a   Kizhake, Smitha ^a,c   Rajarathnam, Krishna ^a   Natarajan, Amarnath ^a,b,c  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

BRCT(BRCA1); NMR; pSXXF tetrapeptide; Structure; Thermodynamics

Indexed keywords

BRCA1 PROTEIN; PHENYLALANINE; SERINE; TETRAPEPTIDE;

ARTICLE; BINDING AFFINITY; CALORIMETRY; ENTHALPY; ENTROPY; HYDROPHOBICITY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE;

AMINO ACID MOTIFS; BRCA1 PROTEIN; DRUG DESIGN; HUMANS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; OLIGOPEPTIDES; PROTEIN BINDING; PROTEIN CONFORMATION; THERMODYNAMICS;

EID: 77649186561     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.01.098     Document Type: Article

References (16)

1. Futreal P.A., et al. BRCA1 mutations in primary breast and ovarian carcinomas. Science 266 (1994) 120-122
2. Starita L.M., and Parvin J.D. The multiple nuclear functions of BRCA1: transcription, ubiquitination and DNA repair. Curr. Opin. Cell Biol. 15 (2003) 345-350
3. Cantor S.B., et al. BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell 105 (2001) 149-160
4. Manke I.A., Lowery D.M., Nguyen A., and Yaffe M.B. BRCT repeats as phosphopeptide-binding modules involved in protein targeting. Science 302 (2003) 636-639
5. Yu X., Chini C.C., He M., Mer G., and Chen J. The BRCT domain is a phospho-protein binding domain. Science 302 (2003) 639-642
6. Wang B., Matsuoka S., Ballif B.A., Zhang D., Smogorzewska A., Gygi S.P., and Elledge S.J. Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response. Science 316 (2007) 1194-1198
7. Yu X., and Chen J. DNA damage-induced cell cycle checkpoint control requires CtIP, a phosphorylation-dependent binding partner of BRCA1 C-terminal domains. Mol. Cell Biol. 24 (2004) 9478-9486
8. Botuyan M.V., Nomine Y., Yu X., Juranic N., Macura S., Chen J., and Mer G. Structural basis of BACH1 phosphopeptide recognition by BRCA1 tandem BRCT domains. Structure 12 (2004) 1137-1146
9. Clapperton J.A., Manke I.A., Lowery D.M., Ho T., Haire L.F., Yaffe M.B., and Smerdon S.J. Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer. Nat. Struct. Mol. Biol. 11 (2004) 512-518
10. Shen Y., and Tong L. Structural evidence for direct interactions between the BRCT domains of human BRCA1 and a phospho-peptide from human ACC1. Biochemistry 47 (2008) 5767-5773
11. Shiozaki E.N., Gu L., Yan N., and Shi Y. Structure of the BRCT repeats of BRCA1 bound to a BACH1 phosphopeptide: implications for signaling. Mol. Cell 14 (2004) 405-412
12. Varma A.K., Brown R.S., Birrane G., and Ladias J.A. Structural basis for cell cycle checkpoint control by the BRCA1-CtIP complex. Biochemistry 44 (2005) 10941-10946
13. Williams R.S., Lee M.S., Hau D.D., and Glover J.N.M. Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1. Nat. Struct. Mol. Biol. 11 (2004) 519-525
14. Lokesh G.L., Muralidhara B.K., Negi S.S., and Natarajan A. Thermodynamics of phosphopeptide tethering to BRCT: the structural minima for inhibitor design. J. Am. Chem. Soc. 129 (2007) 10658-10659
15. Weigelt J. Single scan, sensitivity- and gradient-enhanced TROSY for multidimensional NMR experiments. J. Am. Chem. Soc. 120 (1998) 10778-10779
16. Ravindran A., Joseph P.R., and Rajarathnam K. Structural basis for differential binding of IL-8 monomer and dimer to CXCR1 N-domain: role of coupled interactions and dynamics. Biochemistry 48 (2009) 8795-8805